Steve Schonfeld Schonfeld Strategic Advisors
Steve Schonfeld is the founder of Schonfeld Strategic Advisors, a multi-manager investment firm with roots in proprietary trading. Schonfeld allocates capital across quantitative and discretionary strategies with an emphasis on risk controls and diversification of return streams. The firm is a major name in the multi-strategy hedge fund landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$93.2M |
| 2 |
Fortive
FTV
|
+$32.4M |
| 3 |
Keurig Dr Pepper
KDP
|
+$30.9M |
| 4 |
Wynn Resorts
WYNN
|
+$24.7M |
| 5 |
GB
Global Blue Group Holding
GB
|
+$21.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Equitable Holdings
EQH
|
+$22.7M |
| 2 |
FPAC.U
Far Point Acquisition Corporation Units, each consisting of one share of Class A common stock, $0.00
FPAC.U
|
+$22.4M |
| 3 |
Sherwin-Williams
SHW
|
+$21.1M |
| 4 |
Morgan Stanley
MS
|
+$12.4M |
| 5 |
Visa
V
|
+$11.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.28% |
| 2 | Consumer Discretionary | 16.32% |
| 3 | Industrials | 14.02% |
| 4 | Technology | 11.54% |
| 5 | Financials | 8.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
426
MSCI
MSCI
$41B
| $1.01M | 0.04% |
+5,700
| New | +$990K |
|
427
Regeneron Pharmaceuticals
REGN
$85.9B
| $1.01M | 0.04% |
2,500
-2,400
| -49% | -$913K |
|
428
CGI
GIB
$15.5B
| $1.01M | 0.04% |
+15,600
| New | +$1.01M |
|
429
Wave Life Sciences
WVE
$1.04B
| $1M | 0.04% |
20,000
-10,000
| -33% | -$451K |
|
430
Keysight
KEYS
$53.8B
| $988K | 0.04% |
14,900
+1,630
| +12% | +$101K |
|
|
431
Equitable Holdings
EQH
$13.3B
| $981K | 0.04% |
45,751
-1,036,549
| -96% | -$22.7M |
|
432
Expedia Group
EXPE
$38.6B
| $966K | 0.04% |
7,400
+2,918
| +65% | +$379K |
|
433
Texas Instruments
TXN
$241B
| $966K | 0.04% |
+9,000
| New | +$1M |
|
434
OneMain Financial
OMF
$7.27B
| $958K | 0.04% |
+28,500
| New | +$998K |
|
|
MRO
435
DELISTED
Marathon Oil Corporation
MRO
| $950K | 0.04% |
40,800
+30,200
| +285% | +$632K |
|
|
LSXMA
436
DELISTED
Liberty Media Corporation Series A Liberty SiriusXM Common Stock
LSXMA
| $947K | 0.04% |
30,174
+20,039
| +198% | +$672K |
|
437
Aclaris Therapeutics
ACRS
$944M
| $944K | 0.04% |
65,000
-100
| -0.2% | -$1.71K |
|
438
Landstar System
LSTR
$6.33B
| $939K | 0.04% |
+7,697
| New | +$891K |
|
439
Lincoln Electric
LECO
$15.4B
| $937K | 0.04% |
10,029
+4,155
| +71% | +$384K |
|
440
Cartesian Therapeutics
RNAC
$304M
| $933K | 0.04% |
+2,000
| New | +$804K |
|
|
TFCFA
441
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
| $922K | 0.04% |
+19,898
| New | +$912K |
|
442
NeoGenomics
NEO
$2.18B
| $921K | 0.04% |
+60,000
| New | +$829K |
|
443
State Street Energy Select Sector SPDR ETF
XLE
$41.8B
| $917K | 0.04% |
+24,210
| New | +$908K |
|
444
Conagra Brands
CAG
$7.89B
| $914K | 0.04% |
+26,900
| New | +$983K |
|
445
Madison Square Garden
MSGS
$9.78B
| $914K | 0.04% |
4,066
+1,343
| +49% | +$298K |
|
446
Las Vegas Sands
LVS
$30.5B
| $908K | 0.04% |
+15,300
| New | +$1.03M |
|
447
CoStar Group
CSGP
$13.1B
| $897K | 0.04% |
+21,320
| New | +$911K |
|
|
XHR
448
Xenia Hotels & Resorts
XHR
$1.79B
| $896K | 0.04% |
37,800
-8,900
| -19% | -$215K |
|
449
PACCAR
PCAR
$69B
| $893K | 0.04% |
+19,650
| New | +$867K |
|
450
Encompass Health
EHC
$11.9B
| $889K | 0.04% |
14,330
+7,530
| +111% | +$458K |
|
Similar funds
Steve Schonfeld's Q3 2018 Portfolio in Review
As of Q3 2018, Steve Schonfeld held 1,145 positions worth $2.25B, up 22% from $1.84B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Steve Schonfeld deployed $2.31B of net new capital in Q3 2018, opening 406 new positions and adding to 187 existing holdings. Its largest new stake was Fortive: 632,433 shares worth $33.6M.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 22% a quarter earlier, followed by Consumer Discretionary and Industrials.
On the sell side, the largest reduction was Equitable Holdings, an estimated $22.7M trimmed.
- Steve Schonfeld's largest Q3 2018 buy was Fortive: 632,433 shares worth $33.6M.
- Steve Schonfeld added most to State Street SPDR S&P 500 ETF Trust in Q3 2018, an estimated $93.2M increase.
- Steve Schonfeld's biggest Q3 2018 reduction was Equitable Holdings, cutting an estimated $22.7M.
- Steve Schonfeld fully exited Far Point Acquisition Corporation Units, each consisting of one share of Class A common stock, $0.00 in Q3 2018, selling an estimated $22.4M.
- Steve Schonfeld's ten largest holdings make up 15% of its $2.25B portfolio in Q3 2018.
- Steve Schonfeld opened 406 new positions and closed 367 in Q3 2018.
- Steve Schonfeld's portfolio value rose 22% quarter-over-quarter to $2.25B.
Based on Schonfeld Strategic Advisors's 13F filing for Q3 2018, filed 14 Nov 2018.